Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma
-
Published:2020-06
Issue:
Volume:132
Page:150-158
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Lee Jiyun,
Choi Yoon La,
Jung Hyun Ae,
Lee Se-Hoon,
Ahn Jin Seok,
Ahn Myung-Ju,
Park KeunchilORCID,
Sun Jong-Mu
Subject
Cancer Research,Oncology
Reference27 articles.
1. The 2015 World Health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification;Travis;J Thorac Oncol,2015
2. Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma;Lee;Lung Canc,2018
3. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma;Vieira;J Thorac Oncol,2013
4. Pulmonary sarcomatoid carcinoma: an analysis of the national cancer data base;Steuer;Clin Lung Canc,2017
5. Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis;Yendamuri;Surgery,2012
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献